跳至主要内容
临床试验/JPRN-UMIN000013082
JPRN-UMIN000013082已完成未知

A phase II trial of palonosetron and 1-day dexamethasone and 3-day aprepitant to prevent nausea and vomiting in patients receiving paclitaxel and carboplatin - PALODEX-A trial

ara Medical University0 个研究点目标入组 70 人开始时间: 2014年2月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1.Serious complication as followings; interstitial pneumonia; pulmonary fibrosis; heartfailure; renal failure; hepatic failure; uncontrolled diabetes mellitus etc. 2.Patients with symptomatic brain metastasis. 3.Receiving antiseizure medications. 4.Severe ascites and / or pleural effusion. 5.Bowel obstruction. 6.Symptom of emesis. 7.Hypersensitivity to have a history aprepitant and / or palonosetron and / or other 5-HT3 receptor antagonists and / or Hypersensitivity to have a history dexamethazone. . 8.Receiving pimozide 9.Pregnancy or lactation. 10.Previous history of receiving aprepitant and / or palonosetron. 11.Patient who doesn't have ability or intention that cooperates for procedure of the study 12.Inappropriate patients for this study judged by the physicians

研究者

发起方
ara Medical University

相似试验